✦ LIBER ✦

Gene therapy of malignant glioma via inhibition of tumor angiogenesis

✍ Scribed by Karl H. Plate

Publisher: Springer
Year: 1996
Tongue: English
Weight: 270 KB
Volume: 15
Category: Article
ISSN: 0167-7659
DOI: 10.1007/bf00437477

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metronomic treatment of malignant glioma

Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth

✍ Shingo Takano; Hiroshi Kamiyama; Ryota Mashiko; Satoru Osuka; Eiichi Ishikawa; A 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 543 KB

Experimental study on the gene therapy o

Experimental study on the gene therapy of malignant glioma with antisense VEGF RNA

✍ Pei-yu Pu; Jian-zhen Wang; Qiang Huang; Jing Zhang; Yun-ting Zhang 📂 Article 📅 2003 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 1011 KB

Inhibition of angiogenesis by interleuki

Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis

✍ Christian S. Haas; M. Asif Amin; Brittany B. Allen; Jeffrey H. Ruth; G. Kenneth 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

Vaccination with tumor cell lysate-pulse

Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-β gene therapy for malignant glioma in an experimental mouse intracranial glioma

✍ Ryuta Saito; Masaaki Mizuno; Norimoto Nakahara; Takaya Tsuno; Toshihiro Kumabe; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 1 views

## Abstract Interferon‐β (IFN‐β) has been used as an antitumor drug against human glioma, melanoma and medulloblastoma since the 1980s. Recently, we developed a new gene therapy using the __IFN__‐β gene against malignant gliomas and then began clinical trials in 2000. Since stimulation of immune sy

Gene transfer of NK4, an angiogenesis in

Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation

✍ Takeshi Kubota; Hiroaki Taiyoh; Atsushi Matsumura; Yasutoshi Murayama; Daisuke I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 506 KB

## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in malignant behaviors, such as invasion and metastasis, in different tumors. Hence, HGF could be a target molecule for control of the malignant potential of cancer. NK4 is a competitive antagonist for HGF and exerts an antitu

Lovastatin and tumor necrosis factor-α e

Lovastatin and tumor necrosis factor-α exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor Via inhibition of tumor-induced angiogenesis

✍ Wojciech Feleszko; Ewa Z. Bałkowiec; Elisabeth Sieberth; Maria Marczak; Anna Dab 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 153 KB

Lovastatin, a drug commonly used in the treatment of hypercholesterolemia, has previously been reported to exert potentiated antitumor activity when combined with either tumor necrosis factor-␣ (TNF-␣), cisplatin or doxorubicin in a melanoma model in mice. Since lovastatin interferes with the functi